FFIV
50
-2
PNC
63
-2
PLD
32
-3
EA
47
-3
GWW
64
2
DUK
57
2
UNH
34
-2
CMG
57
-6
BDX
59
-2
FITB
66
-6
TROW
59
-3
R
63
-3
NAVI
30
-2
XYL
33
-2
AA
70
-3
MTB
69
-6
XRAY
28
-3
BBY
43
-3
STI
27
16
EQT
53
3
FFIV
50
-2
PNC
63
-2
PLD
32
-3
EA
47
-3
GWW
64
2
DUK
57
2
UNH
34
-2
CMG
57
-6
BDX
59
-2
FITB
66
-6
TROW
59
-3
R
63
-3
NAVI
30
-2
XYL
33
-2
AA
70
-3
MTB
69
-6
XRAY
28
-3
BBY
43
-3
STI
27
16
EQT
53
3
Financhill
Back

Voyager Therapeutics, Inc. Vs. Neurocrine Biosciences, Inc. Industry Stock Comparison

Sell
23

VYGR
Voyager Therapeutics, Inc.

Last Price:
$4.02
Seasonality Move:
9.68%
Buy
62

NBIX
Neurocrine Biosciences, Inc.

Last Price:
$142.88
Seasonality Move:
4.8%
Sell
23
Voyager Therapeutics, Inc. (VYGR) is a Sell

Is Voyager Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Voyager Therapeutics, Inc. [VYGR] share price is $4.04. The Score for VYGR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • VYGR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Neurocrine Biosciences, Inc. (NBIX) is a Buy

Is Neurocrine Biosciences, Inc. a Buy, Sell or Hold?

  • The current Neurocrine Biosciences, Inc. [NBIX] share price is $143.64. The Score for NBIX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VYGR Stock Price Chart

What is Voyager Therapeutics, Inc.'s stock price today?

  • The Voyager Therapeutics, Inc. share price today is $4.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYGR is experiencing slight selling pressure.

NBIX Stock Price Chart

What is Neurocrine Biosciences, Inc.'s stock price today?

  • The Neurocrine Biosciences, Inc. share price today is $143.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.

VYGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.13 Buy
Relative Strength Index (14 RSI): 44.26 Sell
Chaikin Money Flow: -85299 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4 - 4.34) Sell
Bollinger Bands (100): (3.72 - 4.72) Sell

NBIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 42.16 Sell
Chaikin Money Flow: -461042 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.27 - 154.17) Sell
Bollinger Bands (100): (135.48 - 149.34) Buy

VYGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.1 Sell
20-day SMA: 4.2 Sell
50-day SMA: 4.31 Sell
200-day SMA: 3.76 Buy
8-day EMA: 3.53 Buy
20-day EMA: 2.25 Buy
50-day EMA: 1.12 Buy
200-day EMA: 0.31 Buy

NBIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 144.9 Sell
20-day SMA: 150.01 Sell
50-day SMA: 146.76 Sell
200-day SMA: 130.6 Buy
8-day EMA: 146.18 Sell
20-day EMA: 147.62 Sell
50-day EMA: 146.25 Sell
200-day EMA: 136.58 Buy

Voyager Therapeutics, Inc. Earnings Growth & VYGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.18 per share, and an increase next year of $0.53 per share.

Neurocrine Biosciences, Inc. Earnings Growth & NBIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $2.26 per share.

Voyager Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurocrine Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):